Sullivan Timothy Eugene
CIK 1707000
Transactions on file
28
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 58,140 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 34,447 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 11,874 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 6,872 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 58,140 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Grant | 58,140 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 29,070 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Grant | 29,070 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 30,620 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Grant | 30,620 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Disp. | 41,250 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Grant | 41,250 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | U | 71,492 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | U | 140,945 | $0.00 | — | open → |
| 2026-04-20 | 2026-04-17 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Gift | 11,096 | $0.00 | — | open → |
| 2026-04-20 | 2026-04-17 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Gift | 11,096 | $0.00 | — | open → |
| 2025-01-03 | 2024-12-31 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Exer. | 1,042 | $15.6K | -76.0% | open → |
| 2025-01-03 | 2024-12-31 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Exer. | 10,054 | $139.2K | -74.1% | open → |
| 2025-01-14 | 2025-01-13 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 2,170 | $62.3K | -87.5% | open → |
| 2025-01-21 | 2025-01-17 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 1,730 | $51.8K | -88.0% | open → |
| 2025-01-21 | 2025-01-21 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Grant | 45,929 | $0.00 | — | open → |
| 2025-01-23 | 2025-01-22 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 3,088 | $94.0K | -88.2% | open → |
| 2025-01-30 | 2025-01-29 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 546 | $16.1K | -87.8% | open → |
| 2025-10-23 | 2025-10-21 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 10,000 | $280.3K | -87.2% | open → |
| 2025-10-23 | 2025-10-21 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Exer. | 10,000 | $100.3K | -64.2% | open → |
| 2025-09-10 | 2025-09-08 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 10,000 | $278.3K | -87.1% | open → |
| 2025-09-10 | 2025-09-08 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Exer. | 15,000 | $150.4K | -64.2% | open → |
| 2025-09-10 | 2025-09-08 | APLS Apellis Pharmaceuticals, Inc. | Officer Chief Financial Officer | Sale | 32,729 | $911.8K | -87.1% | open → |
